citalopram has been researched along with Osteoporosis, Postmenopausal in 1 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diem, SJ | 1 |
| Joffe, H | 1 |
| Larson, JC | 1 |
| Tsai, JN | 1 |
| Guthrie, KA | 1 |
| LaCroix, AZ | 1 |
| Ensrud, KE | 1 |
| Freeman, EW | 1 |
| Leder, BZ | 1 |
1 trial available for citalopram and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Effects of escitalopram on markers of bone turnover: a randomized clinical trial.
Topics: Biomarkers; Bone Remodeling; Citalopram; Collagen Type I; Double-Blind Method; Female; Follow-Up Stu | 2014 |